Wenn der Vorhang fällt, tickt die Uhr

1. S2e-Leitlinie Retinale arterielle Verschlüsse (RAV). AWMF-Registernummer: 045-013, Stand Oktober 2022

2. Smith MJ, Benson MD, Tennant M, Jivraj I. Central retinal artery occlusion: a retrospective study of disease presentation, treatment, and outcomes. Can J Ophthalmol 2022; https://doi.org/10.1016/j.jcjo.2022.02.015

3. Fallico M et al. Risk of acute stroke in patients with retinal artery occlusion: a systematic review and meta-analysis. Eye (Lond) 2020; https://doi.org/10.1038%2Fs41433-019-0576-y

4. Lavin P et al. Stroke Risk and Risk Factors in Patients With Central Retinal Artery Occlusion. Am J Ophthalmol 2019; https://doi.org/10.1016/j.ajo.2018.08.027

5. A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion (THEIA), ClinicalTrials.gov Identifier: NCT03197194

6. Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION), ClinicalTrials.gov Identifier: NCT04965038

7. Schrag M et al. Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis. JAMA Neurol 2015; https://doi.org/10.1001/jamaneurol.2015.1578